Double-Blinded Trial Syrup for Hypertension Study from Canada
A flavored syrup placebo in single-dose vials for oral administration in double-blinded hypertension drug trials, matching the active comparator's viscosity and color. Classified under HTS 3006.93.60.00 for blinded clinical trial kits in liquid form per Note 6(e).
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Include blinded protocol from IRB-approved trial demonstrating measured doses for oral intake to differentiate from general syrups
• Ensure cold-chain documentation if refrigerated, as customs may inspect for pharmaceutical waste under Note 6(k)
• Avoid retail packaging; use institutional labeling to prevent reclassification as consumer beverage